Arterra Bioscience SpA (IT:ARBS) has released an update.
Arterra Bioscience S.p.A., a green biotech company listed on the Euronext Growth Milan market, reported a 7% increase in revenue, reaching approximately 2.8 million Euros by September 30, 2024. The growth was primarily driven by the sale of cosmetic raw materials, which saw a 7.25% rise. The company remains optimistic about its financial outlook for the year.
For further insights into IT:ARBS stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
